Minoryx Therapeutics

Minoryx Therapeutics

Verified
Clinical stage biotech company focusing on the development of novel therapies for orphan CNS diseases with high unmet medical needs

Financials

Edit
Revenues, earnings & profits over time
EUR2016201720182019202020212022E
Revenues<1m<1m<1m2m4m--
% growth500 %400 %(83 %)3900 %100 %--
EBITDA<1m<1m<1m<1m(1m)--
% EBITDA margin(1000 %)(33 %)(1200 %)5 %(25 %)--

Source: Company fillings or news article

  • Edit

Recent News about Minoryx Therapeutics

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.